Does Endometriosis Hinder Successful Ovarian DebulkingSurgery?

Panya Sananpanichkul, Supanee Muangtan, Wineeya Suknikhom, Kornkarn Bhamarapravatana, Komsun Suwannarurk
Asian Pacific journal of cancer prevention : APJCP · 2018 · vol. 19(2) , pp. 509–512 · doi:10.22034/apjcp.2018.19.2.509 · PMID:29480993 · PMC5980942 · W2788102299
article OA: gold CC0
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

Endometriosis coexisting with epithelial ovarian cancer was associated with a higher rate of optimal surgical debulking compared to non-endometriosis cases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

This retrospective records review studied 172 patients with epithelial ovarian cancer treated between 2011 and 2016, excluding recurrent cases, and assessed clinicopathologic factors (including CA-125 and surgical/pathologic outcomes) with emphasis on ovarian cancer coexisting with endometriosis (EAOC). EAOC was present in nearly one-fifth of cases, and nulliparity and smoking were associated with higher risk of EAOC development. Although age, familial history of cancer, and endometriosis coexistence were associated with surgical outcome, the EAOC group had a higher proportion of optimal ovarian cancer debulking surgery than the non-EAOC group (61.3% vs 41.8%, statistically significant), and the paper concludes that endometriosis coexistence does not hinder successful debulking. This paper is centrally about endometriosis — it evaluates whether endometriosis coexisting with epithelial ovarian cancer affects the success of ovarian cancer debulking surgery.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: Endometriosis has a significant effect on many aspects of women’s lives, also increasing the risk of ovarian cancer. Although endometriosis is considered as a benign condition, it sometimes behaves like cancer. Methods: All medical records of epithelial ovarian cancer patients during January 2011 to December 2016 were reviewed. Recurrent cases were excluded. Data collected included age at diagnosis, parity, marital status, familial history of cancer, menopausal status, weight, height, smoking histroy, contraception, CA 125 level, result of surgery and pathological report. Results: One hundred and seventy-two medical records of patients with epithelial ovarian cancer (EOC) were included. Average age at diagnosis was 52.3 years. Epithelial ovarian cancer coexisting with endometriosis (EAOC) was found in nearly one-fifth of cases. Nullipara and smoking were associated with 2.3 and 8.3 fold higher risk of EAOC development (aOR 2.349, 95%CI 1.012-5.451; aOR 8.26, 95%CI 1.234-55.278; respectively). Age, familial history of cancer and coexistence with endometriosis were factors related to surgical outcome. More of EAOC group had optimal surgery compared to the non-EAOC group (61.3% and 41.8%) with statistical significance. Conclusion: Younger age, familial history of cancer and coexistence of endometriosis were factors related to optimal surgery. Success of optimal surgery is greater in EAOC than in non-EAOC patients. Coexistence of endometriosis does not hinder successful ovarian cancer debulking surgery.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Ovarian Neoplasms Ovarian Neoplasms Ovary Ovary CA-125 Antigen CA-125 Antigen Carcinoma, Ovarian Epithelial Cytoreduction Surgical Procedures Cytoreduction Surgical Procedures Endometriosis Endometriosis Endometriosis Female Humans Middle Aged Neoplasms, Glandular and Epithelial Neoplasms, Glandular and Epithelial Neoplasms, Glandular and Epithelial Neoplasms, Glandular and Epithelial

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:19:55.107525+00:00
License: CC0 · commercial use OK